FDA panel backs 6 peptides despite its own scientists’ objections

3 months ago 13

An FDA panel voted to allow six peptides for pharmacy compounding despite safety objections and conflicts of interest.

An FDA advisory panel has voted to loosen restrictions on six popular wellness peptides — overruling its own scientists’ warnings.

Read Entire Article